ARAY
Price
$1.53
Change
+$0.01 (+0.66%)
Updated
Apr 23 closing price
Capitalization
244.95M
6 days until earnings call
BRKR
Price
$37.89
Change
+$0.93 (+2.52%)
Updated
Apr 23 closing price
Capitalization
12.93B
13 days until earnings call
Ad is loading...

ARAY vs BRKR

Header iconARAY vs BRKR Comparison
Open Charts ARAY vs BRKRBanner chart's image
Accuray
Price$1.53
Change+$0.01 (+0.66%)
Volume$424.39K
Capitalization244.95M
Bruker
Price$37.89
Change+$0.93 (+2.52%)
Volume$2.19M
Capitalization12.93B
ARAY vs BRKR Comparison Chart
Loading...
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARAY vs. BRKR commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAY is a StrongBuy and BRKR is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (ARAY: $1.53 vs. BRKR: $37.89)
Brand notoriety: ARAY and BRKR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ARAY: 76% vs. BRKR: 95%
Market capitalization -- ARAY: $244.95M vs. BRKR: $12.93B
ARAY [@Medical Specialties] is valued at $244.95M. BRKR’s [@Medical Specialties] market capitalization is $12.93B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARAY’s FA Score shows that 0 FA rating(s) are green whileBRKR’s FA Score has 1 green FA rating(s).

  • ARAY’s FA Score: 0 green, 5 red.
  • BRKR’s FA Score: 1 green, 4 red.
According to our system of comparison, BRKR is a better buy in the long-term than ARAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARAY’s TA Score shows that 6 TA indicator(s) are bullish while BRKR’s TA Score has 6 bullish TA indicator(s).

  • ARAY’s TA Score: 6 bullish, 3 bearish.
  • BRKR’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, BRKR is a better buy in the short-term than ARAY.

Price Growth

ARAY (@Medical Specialties) experienced а +4.79% price change this week, while BRKR (@Medical Specialties) price change was +0.40% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.05%. For the same industry, the average monthly price growth was -8.45%, and the average quarterly price growth was -3.85%.

Reported Earning Dates

ARAY is expected to report earnings on Aug 14, 2025.

BRKR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+3.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BRKR($12.9B) has a higher market cap than ARAY($245M). ARAY YTD gains are higher at: -22.727 vs. BRKR (-35.293). BRKR has higher annual earnings (EBITDA): 676M vs. ARAY (5.93M). BRKR has more cash in the bank: 488M vs. ARAY (72.8M). ARAY has less debt than BRKR: ARAY (202M) vs BRKR (1.38B). BRKR has higher revenues than ARAY: BRKR (2.96B) vs ARAY (447M).
ARAYBRKRARAY / BRKR
Capitalization245M12.9B2%
EBITDA5.93M676M1%
Gain YTD-22.727-35.29364%
P/E RatioN/A32.04-
Revenue447M2.96B15%
Total Cash72.8M488M15%
Total Debt202M1.38B15%
FUNDAMENTALS RATINGS
ARAY vs BRKR: Fundamental Ratings
ARAY
BRKR
OUTLOOK RATING
1..100
5966
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
10095
SMR RATING
1..100
9193
PRICE GROWTH RATING
1..100
8590
P/E GROWTH RATING
1..100
389
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BRKR's Valuation (64) in the Medical Specialties industry is in the same range as ARAY (85). This means that BRKR’s stock grew similarly to ARAY’s over the last 12 months.

BRKR's Profit vs Risk Rating (95) in the Medical Specialties industry is in the same range as ARAY (100). This means that BRKR’s stock grew similarly to ARAY’s over the last 12 months.

ARAY's SMR Rating (91) in the Medical Specialties industry is in the same range as BRKR (93). This means that ARAY’s stock grew similarly to BRKR’s over the last 12 months.

ARAY's Price Growth Rating (85) in the Medical Specialties industry is in the same range as BRKR (90). This means that ARAY’s stock grew similarly to BRKR’s over the last 12 months.

BRKR's P/E Growth Rating (9) in the Medical Specialties industry is in the same range as ARAY (38). This means that BRKR’s stock grew similarly to ARAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARAYBRKR
RSI
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
61%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
69%
MACD
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
67%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
69%
Declines
ODDS (%)
Bearish Trend 9 days ago
79%
Bearish Trend 4 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
70%
View a ticker or compare two or three
Ad is loading...
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CUSCX9.810.10
+1.03%
Cullen Small Cap Value C
DGIFX21.42N/A
N/A
Disciplined Growth Investors
PINIX13.35N/A
N/A
Principal International Equity Inst
GTCEX24.47N/A
N/A
Glenmede Strategic Equity
SLYCX13.14N/A
N/A
SEI Large Cap Y (SIMT)

ARAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with IQV. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
+0.66%
IQV - ARAY
44%
Loosely correlated
+2.40%
ALGN - ARAY
41%
Loosely correlated
+1.93%
BRKR - ARAY
39%
Loosely correlated
+2.52%
UTMD - ARAY
39%
Loosely correlated
-1.06%
ATRC - ARAY
37%
Loosely correlated
+1.63%
More

BRKR and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRKR has been closely correlated with A. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BRKR jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRKR
1D Price
Change %
BRKR100%
+2.52%
A - BRKR
71%
Closely correlated
+2.13%
RVTY - BRKR
69%
Closely correlated
+1.46%
IQV - BRKR
62%
Loosely correlated
+2.40%
WAT - BRKR
59%
Loosely correlated
+1.25%
TMO - BRKR
57%
Loosely correlated
-0.71%
More